An academic CRO, built where research happens.
ACRO Inc. (Academic Contract Research Organization) is a Korean CRO embedded within a research-intensive university hospital. We focus on oncology Phase 1 advisory and quantitative pharmacology — combining hospital-level research access with biostatistics depth shaped by national cohort governance and academic research culture.
We operate as a strategic and methodological partner to sponsors and investigators, with three connected pillars: Clinical Solutions for trial design and regulatory pathway support, Research Solutions for evidence generation and publication, and Bio & Medical Intelligence for R&D and policy advisory.
Our work spans Korean and international development programs, with academic university partnerships and a Korea–US bridging collaboration.
Three pillars, one continuum from protocol to policy.
We integrate clinical operations, evidence generation, and intelligence services so sponsors move from feasibility to reimbursement on a single, coherent evidence backbone.
Clinical Solutions
Bridging preclinical science to first-in-human trials. From feasibility and dose strategy through protocol drafting, biostatistical analysis, monitoring oversight, and regulatory advisory, we provide the methodological backbone of early clinical development — anchored in medical insight and statistical depth.
- Site Feasibility & Selection
- PK / PD Modeling
- Protocol Development
- IND Strategy & Submission
- Site Monitoring
- Biostatistics
- Data Use & Regulatory Strategy
Research Solutions
Turning clinical, real-world, and registry data into publications, real-world evidence, and registry insights. Built on academic statistical depth, we partner with investigators and sponsors across the research lifecycle.
Explore Research Solutions
Bio & Medical Intelligence
Translating evidence into strategy. From data-driven value analysis to R&D planning, we connect academic rigor with industry and public-sector decision-making.
Explore Intelligence Solutions
One team. One evidence chain.From clinical question to policy decision.
Clinical development built on medical insight, biostatistical depth, and academic credibility.
Hospital-Anchored
Embedded at the clinical trial center of one of Korea's leading cancer specialty hospitals, with formal partnerships across a network of clinical trial centers nationwide.
Medical and statistical specialists as one team
Clinical insight and biostatistical rigor on every engagement — so studies are designed around the clinical question, and analyzed with the depth it deserves.
From evidence to decision
We carry your program from clinical data through regulatory submission to policy and reimbursement — one continuous evidence chain.
Notes from the bench — on estimands, dose optimization, and the regulatory pathways shaping oncology in 2026.
ACRO biostatisticians and clinical pharmacologists write on the methods, policies, and evidence standards shaping the field.
All insights